Similar Articles
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725
Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
Halil Önder
DOI: 10.4274/tnd.2019.05925
Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort
Ayşe İlksen Çolpak, Duygu Gülmez Sevim, Aslı Tuncer, Sevda Diker, Rana Karabudak, Sibel Kadayıfçılar, Tülay Kansu
DOI: 10.4274/tnd.2018.33230
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Miraç Ayşen Ünsal
DOI: 10.4274/tnd.2019.00187
Demographic and Clinical Characteristics of Patients with Epilepsy Admitting to Neurology Outpatient Clinic of Erzincan University Mengucek Gazi Training and Research Hospital
Alevtina Ersoy, Ceyda Tanoğlu, Hasan Yaşar, Tuğçe Özdemir Gültekin
DOI: 10.4274/tnd.14238
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
Nefati Kıylıoğlu
DOI: 10.4274/tnd.79836
Posterior Auricular Muscle Response: Observations in Brainstem Lesions
Yeşim Gülen Abanoz, Yasin Abanoz, Yasemin Akıncı, Ayşegül Gündüz, Eser Buluş, Melih Tütüncü, Sabahattin Saip, Meral Erdemir Kızıltan
DOI: 10.4274/tnd.57255
Chronic Migraine: Burden, Comorbidities and Treatment
Aynur Özge, Derya Uludüz, Osman Özgür Yalın, Seden Demirci, Ömer Karadaş, Uğur Uygunoğlu, Aksel Siva
DOI: 10.4274/tnd.55563
Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.86977
Mortality in Patients with Multiple Sclerosis
Sümeyra Şamlı, Murat Kürtüncü
DOI: 10.4274/tnd.15921
Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!
Mohamed S A Mohamed
DOI: 10.4274/tnd.65882
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir
DOI: 10.4274/tnd.62144
Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study
Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ
DOI: 10.4274/tnd.37074
Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu
DOI: 10.4274/tnd.87523
Acute Spinal Pseudoathetosis
Mehmet Fevzi Öztekin, Dilara Mermi Dibek
DOI: 10.4274/tnd.27167
Weight Loss and Fingolimod
Nefati Kıylıoğlu
DOI: 10.4274/tnd.87528
The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis
Şenay Yıldız Çelik
DOI: 10.4274/tnd.71354
Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis
Ahmed Serkan Emekli
DOI: 10.4274/tnd.90018
The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis
Özgü Kizek
DOI: 10.4274/tnd.65391
Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?
Tuncay Gündüz
DOI: 10.4274/tnd.28566